Rearming the body’s immune system to fight cancer
We’re developing more precise and more accessible treatment alternatives for patients with solid cancers
Pioneering excellence in the field of immunotherapy
Cartherics creates precisely-defined immunotherapy treatments to combat a variety of cancers. We combine the best components of immune targeting utilising gene editing and CAR technology to advance cell therapy to provide more diverse off-the-shelf treatments for patients. Our team has strong backgrounds in research, development, and product commercialisation. And we partner with leading commercial and academic groups with complementary technology to push the boundaries of cell therapy for cancer.
Some of our partners
Latest news
Cartherics CEO Alan Trounson on “3-person IVF”
By Christine Filippis / February 4, 2021
Legislation to be introduced to Australian Parliament By Leigh Dayton 4 February 2021 Not only is Alan Trounson Cartherics CEO...
Read More
Cartherics Celebrates Academic Achievements
By Christine Filippis / December 21, 2020
Doctoral students achieve key milestones By Leigh Dayton 21 December 2020 As a rough year for all comes to an...
Read More
The world desperately needs science and technology to provide the path forward for all of us living creatures
By Christine Filippis / December 17, 2020
Writing today Research Australia’s INSPIRE magazine, Cartherics CEO Alan Trounson highlights the role GSK plays in supporting medical research December...
Read More
